SUSAN PUMPHREY: Open Payments
NPI 1134243819 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$117 in 7 payments from 7 companies in 2025. Trend: 2023 $221 · 2024 $237 · 2025 $117
Food & beverage: $117
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $21 |
| PFIZER INC. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Hologic Sales and Service, LLC | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Dexcom, Inc. | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Veozah, PREVNAR 20, ENFLONSIA, APTIMA, CAPLYTA, Dexcom G6 Transmitter, BEXSERO.
Industry payments across MO — which companies pay providers there.
